183 related articles for article (PubMed ID: 23292873)
1. High-throughput screening of tumor metastatic-related differential glycoprotein in hepatocellular carcinoma by iTRAQ combines lectin-related techniques.
Qin X; Chen Q; Sun C; Wang C; Peng Q; Xie L; Liu Y; Li S
Med Oncol; 2013 Mar; 30(1):420. PubMed ID: 23292873
[TBL] [Abstract][Full Text] [Related]
2. Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
Sun C; Chen P; Chen Q; Sun L; Kang X; Qin X; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):765-73. PubMed ID: 22751611
[TBL] [Abstract][Full Text] [Related]
3. Development of glycoprotein capture-based label-free method for the high-throughput screening of differential glycoproteins in hepatocellular carcinoma.
Chen R; Tan Y; Wang M; Wang F; Yao Z; Dong L; Ye M; Wang H; Zou H
Mol Cell Proteomics; 2011 Jul; 10(7):M110.006445. PubMed ID: 21474793
[TBL] [Abstract][Full Text] [Related]
4. Multifucosylated Alpha-1-acid Glycoprotein as a Novel Marker for Hepatocellular Carcinoma.
Tanabe K; Kitagawa K; Kojima N; Iijima S
J Proteome Res; 2016 Sep; 15(9):2935-44. PubMed ID: 27354006
[TBL] [Abstract][Full Text] [Related]
5. Human plasma carboxylesterase 1, a novel serologic biomarker candidate for hepatocellular carcinoma.
Na K; Lee EY; Lee HJ; Kim KY; Lee H; Jeong SK; Jeong AS; Cho SY; Kim SA; Song SY; Kim KS; Cho SW; Kim H; Paik YK
Proteomics; 2009 Aug; 9(16):3989-99. PubMed ID: 19658107
[TBL] [Abstract][Full Text] [Related]
6. Straightforward and Highly Efficient Strategy for Hepatocellular Carcinoma Glycoprotein Biomarker Discovery Using a Nonglycopeptide-Based Mass Spectrometry Pipeline.
Cao WQ; Jiang BY; Huang JM; Zhang L; Liu MQ; Yao J; Wu MX; Zhang LJ; Kong SY; Wang Y; Yang PY
Anal Chem; 2019 Oct; 91(19):12435-12443. PubMed ID: 31453685
[TBL] [Abstract][Full Text] [Related]
7. Screening differential expression of serum proteins in AFP-negative HBV-related hepatocellular carcinoma using iTRAQ -MALDI-MS/MS.
He X; Wang Y; Zhang W; Li H; Luo R; Zhou Y; Liao CL; Huang H; Lv X; Xie Z; He M
Neoplasma; 2014; 61(1):17-26. PubMed ID: 24195504
[TBL] [Abstract][Full Text] [Related]
8. Lower serum soluble-EGFR is a potential biomarker for metastasis of HCC demonstrated by N-glycoproteomic analysis.
Hu H; Gao L; Wang C; Li Y; Ma H; Chen L; Qin J; Liu B; Liu Y; Liang C
Discov Med; 2015 May; 19(106):333-41. PubMed ID: 26105696
[TBL] [Abstract][Full Text] [Related]
9. Capturing and identification of differentially expressed fucome by a gel free and label free approach.
Puangpila C; El Rassi Z
J Chromatogr B Analyt Technol Biomed Life Sci; 2015 May; 989():112-21. PubMed ID: 25817263
[TBL] [Abstract][Full Text] [Related]
10. Mass spectrometry analysis of glycoprotein biomarkers in human blood of hepatocellular carcinoma.
Kim KH; Kim JY; Yoo JS
Expert Rev Proteomics; 2019 Jul; 16(7):553-568. PubMed ID: 31145639
[No Abstract] [Full Text] [Related]
11. Proteomic profiling of N-linked glycoproteins identifies ConA-binding procathepsin D as a novel serum biomarker for hepatocellular carcinoma.
Qi YJ; Ward DG; Pang C; Wang QM; Wei W; Ma J; Zhang J; Lou Q; Shimwell NJ; Martin A; Wong N; Chao WX; Wang M; Ma YF; Johnson PJ
Proteomics; 2014 Feb; 14(2-3):186-95. PubMed ID: 24259486
[TBL] [Abstract][Full Text] [Related]
12. Serum protein biomarkers screening in HCC patients with liver cirrhosis by ICAT-LC-MS/MS.
Kang X; Sun L; Guo K; Shu H; Yao J; Qin X; Liu Y
J Cancer Res Clin Oncol; 2010 Aug; 136(8):1151-9. PubMed ID: 20130913
[TBL] [Abstract][Full Text] [Related]
13. Selective isolation and analysis of glycoprotein fractions and their glycomes from hepatocellular carcinoma sera.
Yang G; Cui T; Wang Y; Sun S; Ma T; Wang T; Chen Q; Li Z
Proteomics; 2013 May; 13(9):1481-98. PubMed ID: 23436760
[TBL] [Abstract][Full Text] [Related]
14. Quantitative proteomic analysis for high-throughput screening of differential glycoproteins in hepatocellular carcinoma serum.
Gao HJ; Chen YJ; Zuo D; Xiao MM; Li Y; Guo H; Zhang N; Chen RB
Cancer Biol Med; 2015 Sep; 12(3):246-54. PubMed ID: 26487969
[TBL] [Abstract][Full Text] [Related]
15. Identification of transaldolase as a novel serum biomarker for hepatocellular carcinoma metastasis using xenografted mouse model and clinic samples.
Wang C; Guo K; Gao D; Kang X; Jiang K; Li Y; Sun L; Zhang S; Sun C; Liu X; Wu W; Yang P; Liu Y
Cancer Lett; 2011 Dec; 313(2):154-66. PubMed ID: 22023829
[TBL] [Abstract][Full Text] [Related]
16. ITIH4: Effective Serum Marker, Early Warning and Diagnosis, Hepatocellular Carcinoma.
Li X; Li B; Li B; Guo T; Sun Z; Li X; Chen L; Chen W; Chen P; Mao Y; Zeng Y
Pathol Oncol Res; 2018 Jul; 24(3):663-670. PubMed ID: 28828637
[TBL] [Abstract][Full Text] [Related]
17. Screening for immune-potentiating antigens from hepatocellular carcinoma patients after radiofrequency ablation by serum proteomic analysis.
Shen S; Peng H; Wang Y; Xu M; Lin M; Xie X; Peng B; Kuang M
BMC Cancer; 2018 Jan; 18(1):117. PubMed ID: 29386009
[TBL] [Abstract][Full Text] [Related]
18. Dysregulated serum metabolites in staging of hepatocellular carcinoma.
Wang W; Lv J; Chen N; Lou B; Mao W; Wang P; Chen Y
Clin Biochem; 2018 Nov; 61():7-11. PubMed ID: 30195484
[TBL] [Abstract][Full Text] [Related]
19. One-Pot Two-Nanoprobe Assay Uncovers Targeted Glycoprotein Biosignature.
Dela Rosa MA; Chen WC; Chen YJ; Obena RP; Chang CH; Capangpangan RY; Su TH; Chen CL; Chen PJ; Chen YJ
Anal Chem; 2017 Apr; 89(7):3973-3980. PubMed ID: 28323416
[TBL] [Abstract][Full Text] [Related]
20. Parallel reaction monitoring with multiplex immunoprecipitation of N-glycoproteins in human serum for detection of hepatocellular carcinoma.
Kim KH; Park GW; Jeong JE; Ji ES; An HJ; Kim JY; Yoo JS
Anal Bioanal Chem; 2019 May; 411(14):3009-3019. PubMed ID: 31076819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
